Evidence map›Paper›PMID 17376911›Full record

ArticleJournal of virology2007

Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.

Mar Perez, Roberto Clemente, Clinton S Robison, E Jeetendra, Himangi R Jayakar, Michael A Whitt, Juan C de la Torre

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Pseudotyped Virus for Bandavirus.Advances in experimental medicine and biology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Recombinant vectors as influenza vaccines.Current topics in microbiology and immunology · 2009
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mar PerezDepartment of Molecular Integrative Neuroscience, The Scripps Research Institute, IMM6, 10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
Roberto Clemente
Clinton S Robison
E Jeetendra
Himangi R Jayakar
Michael A Whitt
Juan C de la Torre
University of Tennessee Health Science Center · USScripps Research Institute · US

Funding

Identification of Borna Disease Virus Receptor ProteinsR21AI064820 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DE LA TORRE, JUAN C. · 2005 to 2006
$505k
REPLICATION AND ASSEMBLY OF VESICULAR STOMATITIS VIRUSR01GM053726 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WHITT, MICHAEL A · 1996 to 2000
$188k
NIAID NIH HHS R21 AI064820NIGMS NIH HHS R01 GM53726
6 · The paper itself

Abstract

Borna disease virus (BDV) is an enveloped virus with a nonsegmented negative-strand RNA genome whose organization is characteristic of mononegavirales. However, based on its unique genetics and biological features, BDV is considered to be the prototypic member of a new virus family, Bornaviridae, within the order Mononegavirales. BDV cell entry occurs via receptor-mediated endocytosis, a process initiated by the recognition of an as yet unidentified receptor at the cell surface by the BDV surface glycoprotein (G). The paucity of cell-free virus associated with BDV infection has hindered studies aimed at the elucidation of cellular receptors and detailed mechanisms involved in BDV cell entry. To overcome this problem, we generated and characterized a replication-competent recombinant vesicular stomatitis virus expressing BDV G (rVSVDeltaG*/BDVG). Cells infected with rVSVDeltaG*/BDVG produced high titers (10(7) PFU/ml) of cell-free virus progeny, but this virus exhibited a highly attenuated phenotype both in cell culture and in vivo. Attenuation of rVSVDeltaG*/BDVG was associated with a delayed kinetics of viral RNA replication and altered genome/N mRNA ratios compared to results for rVSVDeltaG*/VSVG. Likewise, incorporation of BDV G into virions appeared to be restricted despite its high levels of expression and efficient processing in rVSVDeltaG*/BDVG-infected cells. Notably, rVSVDeltaG*/BDVG recreated the cell tropism and entry pathway of bona fide BDV. Our results indicate that rVSVDeltaG*/BDVG represents a unique tool for the investigation of BDV G-mediated cell entry, as well as the roles of BDV G in host immune responses and pathogenesis associated with BDV infection.

Indexed as

AnimalsBorna disease virusCell LineChlorocebus aethiopsCHO CellsCricetinaeCricetulusGenetic VectorsGlycoproteinsHeLa CellsHumansMaleMiceMice, Inbred C57BLRatsRats, Inbred LewGlycoproteinsViral Proteins

Identifiers

PMID17376911
PMCPMC1900261
OpenAlexW2059020843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.